Revvity (RVTY) Capital Expenditures Growth (3y) (2012 - 2026)
Revvity (RVTY) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -6.49% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 93.09% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 7.36% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -3.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.12% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | -7.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | -7.41% |
| Apr 5, 2026 | -1.90% |
| Dec 28, 2025 | -8.77% |
| Mar 30, 2025 | -16.00% |
| Sep 29, 2024 | -2.92% |
| Jun 30, 2024 | 2.66% |
| Mar 31, 2024 | 7.63% |
| Dec 31, 2023 | 56.91% |
| Oct 1, 2023 | 3.35% |
| Jul 2, 2023 | -5.73% |
| Apr 2, 2023 | 0.74% |
| Jan 1, 2023 | 4.55% |
| Apr 3, 2022 | 10.71% |
| Oct 3, 2021 | 5.39% |
| Jul 4, 2021 | 6.30% |
| Apr 4, 2021 | -14.19% |
| Jan 3, 2021 | -28.00% |
| Oct 4, 2020 | 22.98% |
| Jul 5, 2020 | 44.73% |
| Apr 5, 2020 | 50.74% |